Biotechnology News RAZADYNE Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-25 out of 42 found

Current Search: razadyne: 42

Disease and Therapy Review of Senile Dementia
- Research and Markets (http://www.researchandmarkets.com/research/ef4799/disease_and_therap) has announced the addition of the 'Disease and Therapy Review: Senile Dementia' report to their offering.

The Senile Dementia Disease and Therapy...

DiGiTAL50: Nov 14 2008 5:31AM
Matching: razadyne

Find similar documents

The Senile Dementia Disease and Therapy...

Pharma Live: Nov 13 2008 2:06PM
Matching: razadyne

Find similar documents

Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer
- Acorda Therapeutics, Inc.

(Nasdaq: ACOR) today announced that Thomas C.

Wessel, M.D., Ph.D., has joined the Company as Chief Medical Officer, reporting to Ron Cohen, M.D., President and CEO.

In this role, Dr.

Wessel will have...

DiGiTAL50: Nov 12 2008 8:02PM
Matching: razadyne

Find similar documents

Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer
Acorda Therapeutics, Inc.

(Nasdaq: ACOR) today announced that Thomas C.

Wessel, M.D., Ph.D., has joined the Company as Chief Medical Officer, reporting to Ron Cohen, M.D., President and CEO.

In this role, Dr.

Wessel will have...

Genetic Engineering News: Nov 12 2008 2:15PM
Matching: razadyne

Find similar documents

Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer
Business Editors/Health/Medical Writers HAWTHORNE, N.Y.--(BUSINESS WIRE)--November 12, 2008--Acorda Therapeutics, Inc.

(Nasdaq: ACOR) today announced that Thomas C.

Wessel, M.D., Ph.D., has joined the Company as Chief Medical Officer,...

Calibre Macro World: Nov 12 2008 12:35PM
Matching: razadyne

Find similar documents

Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer
Previously, Dr.

Wessel was Senior Vice President of Clinical Research at Sepracor, Inc., where he led the central nervous system (CNS) and respiratory medicine development teams, including clinical research and operations, clinical...

Business Wire: Nov 12 2008 12:17PM
Matching: razadyne

Find similar documents

Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc.

(Nasdaq: ACOR - News) today announced that Thomas C.

Wessel, M.D., Ph.D., has joined the Company as Chief Medical Officer, reporting to Ron Cohen, M.D., President and CEO.

In...

Yahoo!: Nov 12 2008 12:16PM
Matching: razadyne

Find similar documents

Myriad Genetics 2008 - A Retrospective
Amid a string of stock disasters, there have been a few bright spots and one such standout is healthcare company Myriad Genetics Inc.

(MYGN | Quote | Chart | News | PowerRating).

Not that everything has been rosy for Myriad this year, as...

TradingMarkets: Nov 12 2008 9:31AM
Matching: razadyne

Find similar documents

Razadyne generic wins FDA approval
Galantamine in Alzheimer's treatment ADAS-cog, CIBIC-plus, and ADCS-ADL results Dosage recommendations Cost-effectiveness Barr Pharmaceuticals Inc., recently announced that its subsidiary, Barr Laboratories Inc., received final approval from...

Drugtopics.com: Nov 10 2008 5:50PM
Matching: razadyne

Find similar documents

SHIRE PLC - New products deliver strong quarterly performance
Press Release www.shire.com Shire's new product portfolio delivers strong quarterly performance October 29, 2008 - Shire plc the global specialty biopharmaceutical company announces results for the three months to September 30, 2008.

Q3...

SmartBrief: Oct 31 2008 10:26PM
Matching: razadyne

Find similar documents

Shire's New Product Portfolio Delivers Strong Quarterly Performance
PHILADELPHIA and DUBLIN, Ireland, Oct.

29 /PRNewswire-FirstCall/ -- Shire plc the global specialty biopharmaceutical company announces results for the three months to September 30, 2008.

Q3 2008 Financial Highlights - Product sales up 31...

SmartBrief: Oct 31 2008 10:30PM
Matching: razadyne

Find similar documents

New products deliver strong quarterly performance
Press Release www.shire.com Shire's new product portfolio delivers strong quarterly performance October 29, 2008 - Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to...

London Stock Exchange: Oct 29 2008 12:07PM
Matching: razadyne

Find similar documents

Shire's New Product Portfolio Delivers Strong Quarterly Performance
PHILADELPHIA and DUBLIN, Ireland, Oct.

29 /PRNewswire-FirstCall/ -- Shire plc the global specialty biopharmaceutical company announces results for the three months to September 30, 2008.

Q3 2008 Financial Highlights - Product sales up 31...

KSLA: Oct 29 2008 7:37PM
Matching: razadyne

Find similar documents

Shire's New Product Portfolio Delivers Strong Quarterly Performance
PHILADELPHIA and DUBLIN, Ireland, Oct.

29 /PRNewswire-FirstCall/ -- Shire plc the global specialty biopharmaceutical company announces results for the three months to September 30, 2008.

Q3 2008 Financial Highlights - Product sales up 31...

Financials.com: Oct 29 2008 7:20PM
Matching: razadyne

Find similar documents

Shire's New Product Portfolio Delivers Strong Quarterly Performance
PHILADELPHIA and DUBLIN, Ireland, Oct.

29 /PRNewswire-FirstCall/ -- Shire plc the global specialty biopharmaceutical company announces results for the three months to September 30, 2008.

Q3 2008 Financial Highlights - Product sales up 31...

KLFY: Oct 29 2008 5:22PM
Matching: razadyne

Find similar documents

Shire's New Product Portfolio Delivers Strong Quarterly Performance
PHILADELPHIA and DUBLIN, Ireland, Oct.

29 /PRNewswire-FirstCall/ -- Shire plc the global specialty biopharmaceutical company announces results for the three months to September 30, 2008.

Q3 2008 Financial Highlights - Product sales up 31...

KOTA Territory News: Oct 29 2008 3:46PM
Matching: razadyne

Find similar documents